KRAS and EGFR inhibitors: a new step in the management of colorectal cancer

Transl Gastroenterol Hepatol. 2024 Sep 4:9:56. doi: 10.21037/tgh-24-73. eCollection 2024.

Authors

Khalil Saleh¹, Rebecca Ibrahim¹, Rita Khoury¹, Zamzam Tikriti¹, Nadine Khalife²

Affiliations

¹ International Department, Gustave Roussy Cancer Campus, Villejuif, France.
² Department of Head and Neck Oncology, Gustave Roussy Cancer Campus, Villejuif, France.

No abstract available

Keywords: KRASG12C mutation; adagrasib; colorectal cancer (CRC); panitumumab; sotorasib.

Publication types

Editorial
Comment